We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+29.59%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$199M
Cap. Flow
-$18M
Cap. Flow %
-1.18%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$7

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$1.03B 67.56%
9,666,038
– –
SANA icon
2
Sana Biotechnology
SANA
$885M
$250M 16.4%
25,001,856
– –
OMGA
3
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$107M 7%
29,225,579
– –
FHTX icon
4
Foghorn Therapeutics
FHTX
$285M
$85M 5.58%
12,674,120
– –
DNLI icon
5
Denali Therapeutics
DNLI
$3.67B
$28M 1.84%
1,364,516
-955,452
-41% -$18M
MCRB icon
6
Seres Therapeutics
MCRB
$48.1M
$17.9M 1.17%
1,155,852
– –
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.92M 0.45%
1,293,849
+1
+0% +$7

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q1 2024 Portfolio in Review

As of Q1 2024, Flagship Pioneering held 7 positions worth $1.52B, up 15% from $1.33B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Flagship Pioneering opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering added most to Syros Pharmaceuticals, Inc. Common Stock in Q1 2024, an estimated $7 increase.
  • Flagship Pioneering's biggest Q1 2024 reduction was Denali Therapeutics, cutting an estimated $18M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $1.52B portfolio in Q1 2024.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q1 2024.
  • Flagship Pioneering's portfolio value rose 15% quarter-over-quarter to $1.52B.

Based on Flagship Pioneering's 13F filing for Q1 2024, filed 15 May 2024.